Hypertrophic Pyloric Stenosis

Alias:

Congenital Hypertrophic Pyloric Stenosis

Pyloric Stenosis, Hypertrophic

Congenital or Infantile Constriction of Pylorus

Congenital or Infantile Obstruction of Pylorus

Congenital or Infantile Stricture of Pylorus

Congenital or Infantile Spasm of Pylorus

Infantile Hypertrophic Pyloric Stenosis

Congenital Constriction of the Pylorus

Congenital Hypertrophy of the Pylorus

Infantile Constriction of the Pylorus

Infantile Hypertrophy of the Pylorus

Congenital Stricture of the Pylorus

Congenital Stenosis of the Pylorus

Infantile Stricture of the Pylorus

Infantile Stenosis of the Pylorus

Infantile Pyloric Obstruction

Infantile Pyloric Hypertrophy

Congenital Pyloric Stricture

Infantile Pyloric Stricture

Congenital Spasm of Pylorus

Congenital Pyloric Stenosis

Infantile Pyloric Stenosis

Achalasia of the Pylorus

Congenital Pyloric Spasm

Congenital Pylorospasm

Pyloric Constriction

Pylorus Achalasia

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Hypertrophic Pyloric Stenosis, also known as congenital hypertrophic pyloric stenosis, is related to pyloric stenosis and pylorospasm. An important gene associated with Hypertrophic Pyloric Stenosis is MLN (Motilin), and among its related pathways/superpathways are Signal Transduction and Neuroscience. The drugs Fentanyl and Rocuronium have been mentioned in the context of this disorder. Affiliated tissues include smooth muscle and pancreas, and related phenotypes are Decreased viability in pancreas lineage and renal/urinary system

Related ID：

MALACARDS：HYP009

MESH：D046248

ICD11：224753192